U.S. Supreme CourtJudgement

No patent on DNA

13 Jun, 2013

Court rules unanimously that a genetics company cannot patent a sequence of naturally occurring human genes, which it discovered and uses to assess patients’ cancer risk. The decision says Myriad Genetics, Inc. can patent cDNA a synthetic composite created by laboratory technicians. Justice Thomas writes:

A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring,

Add your comments below...